InvestorsHub Logo
Followers 38
Posts 996
Boards Moderated 0
Alias Born 11/12/2014

Re: None

Friday, 05/13/2016 9:20:17 AM

Friday, May 13, 2016 9:20:17 AM

Post# of 5001
Sorry boys, down she goes again. Ill go ahead and post my analysis one more time.

1) Cash flows cannot pay debt schedule (not even close)..$22 billion due in 3.5 years and and more after that. (total LT debt obligations are $42 billion principle plus interest)
2) They have zero refinancing options because debt is rated junk.
2) their revenues are supressed, they cant raise prices, and their drugs are coming off patent and will compete with generic.
3) They are under investigation by like 5 agencies. Get ready for massive legal bills.
4) They cut r&d on all their assets purchased and dramatically lowered the value. If they tried to sell an asset it would be at a fire drill price and would also impact their revenue/cash flows even more.
5)Papa only came over to Valeant for the giant 70 million guaranteed payday
6) Papa said the first thing hes doing is trying to keep people at the company...people are leaving. The company is falling apart.
7) They would have to raise r&d dramatically to develope a new drug pipeline (which would take years) and that is money they dont have right now
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BHC News